Tilray Quarterly Cash Flow Statements Chart
Quarterly
|
Annual
Tilray Quarterly Cash Flow Statements Table
Quarterly
|
Annual
Unit: USD | 2025-02-28 | 2024-11-30 | 2024-08-31 | 2024-05-31 | 2023-08-31 | 2022-05-31 | 2022-02-28 | 2021-11-30 | 2021-08-31 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | 2018-12-31 | 2018-09-30 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash from operating activities: | ||||||||||||||||||||
net income | -793,534,000 | -85,275,000 | -34,652,000 | -15,375,000 | -55,863,000 | -457,800,000 | 52,475,000 | 5,797,000 | -34,604,000 | -340,955,000 | -2,949,000 | -2,315,000 | -81,686,000 | -184,123,000 | -220,137,000 | -35,678,000 | -35,053,000 | -30,301,000 | -31,009,000 | -18,700,000 |
adjustments for: | ||||||||||||||||||||
deferred income tax expense (recovery) | 1,157,000 | |||||||||||||||||||
unrealized foreign exchange gain | 21,098,000 | |||||||||||||||||||
amortization | 33,546,000 | 34,050,000 | 31,814,000 | 31,730,000 | 30,789,000 | 40,768,000 | 37,020,000 | 37,471,000 | 39,333,000 | |||||||||||
accretion of convertible debt discount | 2,766,000 | 2,918,000 | 3,067,000 | 2,996,000 | ||||||||||||||||
impairments | ||||||||||||||||||||
other than temporary change in fair value of convertible notes receivable | 0 | |||||||||||||||||||
other non-cash items | -1,778,000 | 2,552,000 | 729,000 | 329,000 | -816,000 | -10,609,000 | -2,777,000 | 3,574,000 | 165,000 | -143,000 | 93,000 | 138,000 | ||||||||
stock-based compensation | 4,035,000 | 7,237,000 | 6,917,000 | 7,252,000 | 8,257,000 | 8,969,000 | 9,355,000 | 13,596,000 | 4,074,000 | |||||||||||
gain on long-term investments & equity investments | 5,474,000 | 7,315,000 | ||||||||||||||||||
(gain) loss on derivative instruments | -1,338,000 | |||||||||||||||||||
change in fair value of contingent consideration | 1,000,000 | -11,107,000 | -15,585,000 | -29,895,000 | ||||||||||||||||
change in non-cash working capital: | ||||||||||||||||||||
accounts receivable | 9,372,000 | -6,709,000 | -2,342,000 | -12,153,000 | 13,044,000 | -3,192,000 | 12,602,000 | -9,868,000 | -1,000,000 | -4,781,000 | 1,928,000 | 11,050,000 | -1,906,000 | -1,718,000 | -11,109,000 | -5,023,000 | 3,030,000 | -11,704,000 | -3,968,000 | |
prepaids and other current assets | 4,788,000 | 524,000 | -13,570,000 | 11,921,000 | -4,654,000 | 5,346,000 | 966,000 | -7,265,000 | ||||||||||||
inventory | 2,550,000 | 4,256,000 | -12,383,000 | -10,949,000 | 3,650,000 | -19,921,000 | -1,513,000 | 4,922,000 | -4,893,000 | -4,589,000 | -4,584,000 | -9,298,000 | -11,594,000 | -28,885,000 | -35,029,000 | -25,746,000 | -12,983,000 | -1,472,000 | -7,802,000 | |
accounts payable and accrued liabilities | -13,132,000 | -16,356,000 | -8,472,000 | 31,194,000 | -6,469,000 | -13,434,000 | -21,913,000 | -22,600,000 | ||||||||||||
net cash from operating activities | -5,761,000 | -40,724,000 | -35,307,000 | 30,707,000 | -15,842,000 | -20,524,000 | -46,390,000 | -17,121,000 | -93,227,000 | -13,008,000 | -24,865,000 | -13,983,000 | -36,472,000 | -54,031,000 | -90,810,000 | -57,028,000 | -85,386,000 | -24,841,000 | -19,808,000 | -23,535,000 |
capex | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -2,466,000 | -5,278,000 | -11,874,000 | -9,202,000 | -18,290,000 | -23,320,000 | -24,158,000 | -17,246,000 | -9,017,000 | 0 | -9,839,000 |
free cash flows | -5,761,000 | -40,724,000 | -35,307,000 | 30,707,000 | -15,842,000 | -20,524,000 | -46,390,000 | -17,121,000 | -93,227,000 | -15,474,000 | -30,143,000 | -25,857,000 | -45,674,000 | -72,321,000 | -114,130,000 | -81,186,000 | -102,632,000 | -33,858,000 | -19,808,000 | -33,374,000 |
cash from investing activities: | ||||||||||||||||||||
investment in capital and intangible assets | -14,414,000 | -5,436,000 | -6,736,000 | -9,710,000 | -4,152,000 | -5,594,000 | -4,614,000 | -7,540,000 | -16,316,000 | |||||||||||
proceeds from disposal of capital and intangible assets | 202,000 | 603,000 | 28,000 | 7,343,000 | 342,000 | 679,000 | 3,262,000 | 568,000 | 7,696,000 | |||||||||||
(purchase) disposal of marketable securities | 14,093,000 | |||||||||||||||||||
business acquisitions, net of cash acquired | 0 | 0 | ||||||||||||||||||
net cash from investing activities | -119,000 | -10,725,000 | -49,395,000 | 45,056,000 | -26,290,000 | -4,915,000 | -1,026,000 | -6,972,000 | -8,620,000 | -69,000 | 203,000 | -12,434,000 | -11,330,000 | -18,119,000 | 11,663,000 | -66,267,000 | -29,081,000 | -169,496,000 | -45,076,000 | -24,591,000 |
cash from financing activities: | ||||||||||||||||||||
share capital issued, net of cash issuance costs | 28,221,000 | 45,045,000 | 66,472,000 | |||||||||||||||||
proceeds from long-term debt | 0 | |||||||||||||||||||
repayment of long-term debt | -5,727,000 | -5,597,000 | -4,791,000 | -4,424,000 | -5,684,000 | -13,791,000 | -12,419,000 | -8,360,000 | ||||||||||||
proceeds from convertible debt | 0 | |||||||||||||||||||
repayment of convertible debt | 0 | 0 | -330,000 | 0 | ||||||||||||||||
repayment of lease liabilities | -862,000 | -862,000 | -862,000 | -129,000 | 0 | -1,312,000 | -3,206,000 | -154,000 | ||||||||||||
net decrease in bank indebtedness | -7,011,000 | |||||||||||||||||||
net cash from financing activities | 18,071,000 | 38,203,000 | 60,590,000 | 7,070,000 | 14,018,000 | 161,808,000 | -5,565,000 | -20,019,000 | -8,028,000 | 234,081,000 | 54,726,000 | 44,909,000 | 5,426,000 | 159,786,000 | 69,602,000 | 39,394,000 | 4,960,000 | 744,000 | 451,331,000 | 123,639,000 |
effect of foreign exchange on cash and cash equivalents | -1,933,000 | -2,242,000 | 958,000 | -746,000 | 614,000 | 326,000 | 412,000 | -402,000 | -2,294,000 | |||||||||||
net decrease in cash and cash equivalents | 10,258,000 | -15,488,000 | -23,154,000 | 82,087,000 | -27,500,000 | 136,695,000 | -52,569,000 | -44,514,000 | -112,169,000 | |||||||||||
cash and cash equivalents, beginning of period | 0 | 0 | 228,340,000 | 0 | 206,632,000 | 0 | 0 | 0 | 488,466,000 | 189,702,000 | 0 | 0 | 0 | 96,791,000 | 0 | 0 | 0 | 487,255,000 | 0 | |
cash and cash equivalents, end of period | 10,258,000 | -15,488,000 | 205,186,000 | 82,087,000 | 179,132,000 | 136,695,000 | -52,569,000 | -44,514,000 | 376,297,000 | 416,370,000 | 34,497,000 | 17,994,000 | -36,779,000 | 173,990,000 | -3,368,000 | -84,392,000 | -109,654,000 | 294,205,000 | ||
deferred income tax expense | 382,000 | 24,000 | ||||||||||||||||||
unrealized foreign exchange (gain) loss | -5,602,000 | 10,378,000 | -3,127,000 | |||||||||||||||||
(gain) loss on long-term investments & equity investments | -499,000 | |||||||||||||||||||
loss on derivative instruments | -696,000 | 10,345,000 | ||||||||||||||||||
disposal (purchase) of marketable securities | -42,687,000 | 47,423,000 | ||||||||||||||||||
net increase in bank indebtedness | 101,000 | 3,004,000 | -8,787,000 | |||||||||||||||||
deferred income tax recovery | -31,473,000 | 59,000 | -10,242,000 | -6,068,000 | 13,645,000 | -24,873,000 | ||||||||||||||
gain on sale of capital assets | -51,000 | |||||||||||||||||||
inventory valuation write down | 55,000,000 | 0 | ||||||||||||||||||
loss on long-term investments & equity investments | 47,000 | 1,053,000 | 1,144,000 | |||||||||||||||||
proceeds from warrants and options exercised | ||||||||||||||||||||
shares effectively repurchased for employee withholding tax | ||||||||||||||||||||
dividend paid to nci | ||||||||||||||||||||
(gain) loss on sale of capital assets | ||||||||||||||||||||
loss on sale of capital assets | 3,000 | 203,000 | 27,000 | |||||||||||||||||
purchase of marketable securities | -45,436,000 | |||||||||||||||||||
net cash acquired from business acquisitions | 22,956,000 | |||||||||||||||||||
proceeds from long-term debt and convertible debt | 29,174,000 | |||||||||||||||||||
repayment of long-term debt and convertible debt | -6,369,000 | |||||||||||||||||||
unrealized foreign exchange loss | 16,302,000 | 13,192,000 | ||||||||||||||||||
gain on derivative instruments | -16,930,000 | -77,217,000 | ||||||||||||||||||
transaction costs associated with business acquisitions | ||||||||||||||||||||
promissory notes advances | ||||||||||||||||||||
repayment of notes receivable | ||||||||||||||||||||
change in marketable securities | ||||||||||||||||||||
proceeds from disposal of long-term investments and equity investees | ||||||||||||||||||||
net cash (paid for) acquired in business acquisition | ||||||||||||||||||||
proceeds from convertible debentures issuance | ||||||||||||||||||||
repayment of convertible debentures | ||||||||||||||||||||
net increase in cash and cash equivalents | ||||||||||||||||||||
net cash paid for business acquisition | ||||||||||||||||||||
increase in bank indebtedness | 627,000 | 8,760,000 | -467,000 | 486,000 | ||||||||||||||||
impairment | ||||||||||||||||||||
change in non-cash working capital | ||||||||||||||||||||
proceeds from disposal of marketable securities | ||||||||||||||||||||
investment in long-term investments and equity investees | ||||||||||||||||||||
net cash acquired (paid) on business acquisitions | 0 | |||||||||||||||||||
proceeds (payment) from warrants and options exercised | -134,000 | 778,000 | ||||||||||||||||||
loss on contingent consideration | 845,000 | 837,000 | ||||||||||||||||||
net cash paid on business acquisitions | ||||||||||||||||||||
gain on debt instruments | -57,711,000 | |||||||||||||||||||
net income for the year | ||||||||||||||||||||
loss on promissory notes receivable | ||||||||||||||||||||
gain on convertible debentures | ||||||||||||||||||||
repayment of convertible notes receivable | ||||||||||||||||||||
proceeds from convertible debentures | ||||||||||||||||||||
amounts paid to non-controlling interest | ||||||||||||||||||||
supplementary disclosure of cash flow information | ||||||||||||||||||||
cash paid during the year: | ||||||||||||||||||||
income taxes | ||||||||||||||||||||
operating activities | ||||||||||||||||||||
adjusted for the following items: | ||||||||||||||||||||
inventory valuation adjustments | 2,062,000 | 2,303,000 | 13,443,000 | 18,629,000 | 4,044,000 | |||||||||||||||
depreciation and amortization expenses | 4,908,000 | 4,422,000 | 5,346,000 | 4,325,000 | 4,561,000 | |||||||||||||||
impairment of assets | 2,904,000 | 0 | 28,371,000 | 29,839,000 | ||||||||||||||||
stock-based compensation expenses | 7,193,000 | 6,312,000 | 8,080,000 | 7,647,000 | 7,677,000 | |||||||||||||||
change in fair value of warrant liability | 263,201,000 | 49,011,000 | -31,913,000 | 11,210,000 | 71,978,000 | |||||||||||||||
income from equity method investments | 1,787,000 | 1,488,000 | 1,420,000 | 1,327,000 | 1,748,000 | 2,667,000 | ||||||||||||||
(gain) income from equity investments measured at fair value | -300,000 | |||||||||||||||||||
(gain) income from sale of investment | -75,000 | |||||||||||||||||||
interest on debt securities | -197,000 | -195,000 | -185,000 | -221,000 | ||||||||||||||||
deferred taxes | -635,000 | -1,363,000 | 134,000 | -2,875,000 | -1,272,000 | -4,860,000 | 2,432,000 | -2,642,000 | -3,777,000 | |||||||||||
amortization of discount on convertible notes | 1,653,000 | 2,373,000 | 2,700,000 | 2,647,000 | 2,597,000 | 2,227,000 | 2,583,000 | 2,532,000 | 2,501,000 | |||||||||||
amortization of transaction costs on senior facility | 436,000 | 429,000 | 407,000 | 405,000 | 131,000 | |||||||||||||||
foreign currency (gain) loss | -699,000 | -13,326,000 | 28,069,000 | 126,000 | -214,000 | |||||||||||||||
accretion related to obligations under finance leases | 485,000 | 1,041,000 | 77,000 | 166,000 | 151,000 | |||||||||||||||
issuance costs on registered offering recorded to net income | 0 | 0 | 0 | 3,953,000 | ||||||||||||||||
credit loss expenses | 805,000 | 113,000 | -29,000 | 271,000 | 46,000 | |||||||||||||||
benefit from sales returns | -924,000 | -90,000 | 164,000 | -262,000 | ||||||||||||||||
loss on disposal of property and equipment | 82,000 | 449,000 | -21,000 | 457,000 | 111,000 | |||||||||||||||
changes in non-cash working capital: | ||||||||||||||||||||
prepayments and other current assets | 2,703,000 | -9,667,000 | -1,937,000 | -549,000 | 6,749,000 | |||||||||||||||
accounts payable | 30,513,000 | -7,941,000 | 3,934,000 | -1,260,000 | -15,218,000 | -18,770,000 | 38,081,000 | 927,000 | -235,000 | 1,819,000 | -4,620,000 | |||||||||
accrued expenses and other current liabilities | 20,645,000 | -1,881,000 | -12,810,000 | -3,172,000 | 11,676,000 | 7,086,000 | -2,207,000 | 11,660,000 | 3,890,000 | 3,939,000 | ||||||||||
investing activities | ||||||||||||||||||||
change in deposits and other assets | 176,000 | -2,397,000 | -927,000 | -2,774,000 | -229,000 | |||||||||||||||
investment in equity method investees | -493,000 | |||||||||||||||||||
proceeds from the sale of other investments | 2,719,000 | 0 | 0 | 437,000 | ||||||||||||||||
purchases of property and equipment | -2,466,000 | -5,278,000 | -11,874,000 | -9,202,000 | -18,290,000 | -23,320,000 | -24,158,000 | -17,246,000 | -9,017,000 | |||||||||||
proceeds from disposal of property and equipment | 171,000 | 290,000 | 679,000 | 1,031,000 | 661,000 | |||||||||||||||
financing activities | ||||||||||||||||||||
proceeds from at-the-market equity offering, net of costs | 156,029,000 | 45,230,000 | 3,202,000 | 27,027,000 | ||||||||||||||||
proceeds from abg profit participation arrangement | 0 | 0 | 0 | 1,353,000 | 854,000 | 1,666,000 | ||||||||||||||
proceeds from issuance of registered offering, net of issuance costs | 0 | 0 | 0 | 85,465,000 | ||||||||||||||||
payment of abg finance liability | -375,000 | 0 | -500,000 | 0 | -1,000,000 | |||||||||||||||
proceeds from exercise of warrants | 76,106,000 | |||||||||||||||||||
proceeds from exercise of stock options | 6,117,000 | 5,495,000 | 480,000 | 3,714,000 | 1,813,000 | 573,000 | 471,000 | 3,483,000 | 931,000 | |||||||||||
payment of obligations under finance lease | -103,000 | -101,000 | -105,000 | |||||||||||||||||
payment on the settlement of stock options | -2,487,000 | -119,000 | -198,000 | -198,000 | -748,000 | |||||||||||||||
proceeds from issuance of senior facility, net of transaction costs | 0 | 0 | 0 | 46,395,000 | ||||||||||||||||
repayment of senior facility | -1,309,000 | 0 | 0 | -1,191,000 | -414,000 | |||||||||||||||
effect of foreign currency translation on cash and cash equivalents | 5,664,000 | 4,433,000 | -498,000 | 5,597,000 | -10,437,000 | 6,177,000 | -491,000 | -147,000 | 543,000 | |||||||||||
cash and cash equivalents | ||||||||||||||||||||
increase in cash and cash equivalents | 226,668,000 | 34,497,000 | 17,994,000 | -36,779,000 | 77,199,000 | -3,368,000 | -84,392,000 | -109,654,000 | -193,050,000 | |||||||||||
gain on sale of short-term investment | ||||||||||||||||||||
income from equity investments measured at fair value | 3,011,000 | |||||||||||||||||||
income from sale of investment | 2,375,000 | 0 | 0 | 65,000 | ||||||||||||||||
non-cash interest expenses | ||||||||||||||||||||
benefit from doubtful accounts | 259,000 | 536,000 | ||||||||||||||||||
gain on disposal of property and equipment | ||||||||||||||||||||
gain on convertible debt | ||||||||||||||||||||
accrued expenses and other liabilities | ||||||||||||||||||||
business combinations, net of cash acquired | ||||||||||||||||||||
investment in abg profit participation arrangement | 0 | 0 | 0 | -33,333,000 | ||||||||||||||||
purchases of short-term and other investments | ||||||||||||||||||||
proceeds from sales and maturities of short-term investments | 1,374,992,000 | |||||||||||||||||||
purchases of intangible assets | -3,934,000 | -574,000 | -275,000 | -92,000 | -3,425,000 | -131,000 | ||||||||||||||
proceeds from at-the market equity offering, net of costs | ||||||||||||||||||||
payment under privateer holdings debt facilities | ||||||||||||||||||||
advances under privateer holdings debt and construction facilities | ||||||||||||||||||||
proceeds from preferred shares - series a, net of transaction costs | ||||||||||||||||||||
payment of mortgage debt | ||||||||||||||||||||
proceeds from issuance of convertible notes, net of issuance costs | ||||||||||||||||||||
proceeds from issuance of common stock pursuant to ipo | 7,000 | |||||||||||||||||||
foreign currency loss | ||||||||||||||||||||
investment in equity method investees and s&s acquisition | ||||||||||||||||||||
interest receipts on debt securities | 0 | |||||||||||||||||||
investment in joint venture with ab inbev | -1,415,000 | |||||||||||||||||||
gain from equity investments measured at fair value | -767,000 | 1,534,000 | ||||||||||||||||||
taxes receivable | ||||||||||||||||||||
other liabilities | ||||||||||||||||||||
depreciation and amortization expense | 4,686,000 | 2,985,000 | 2,770,000 | |||||||||||||||||
stock-based compensation expense | 8,315,000 | 7,585,000 | 5,306,000 | 4,111,000 | 11,245,000 | |||||||||||||||
other operating activities | ||||||||||||||||||||
other receivables | -1,691,000 | 3,654,000 | -852,000 | |||||||||||||||||
prepaid expenses and other current assets | -22,644,000 | -29,820,000 | -2,143,000 | 2,098,000 | -3,653,000 | |||||||||||||||
acquisition of manitoba harvest, net of cash acquired | -41,672,000 | -274,000 | -109,057,000 | |||||||||||||||||
acquisition of natura, net of cash acquired | 0 | 0 | -15,083,000 | |||||||||||||||||
purchases of short-term and non-current investments | -106,000 | -5,466,000 | -2,914,000 | |||||||||||||||||
disposals of property and equipment | ||||||||||||||||||||
repayment under privateer debt facilities | ||||||||||||||||||||
advances under privateer debt and construction facilities | ||||||||||||||||||||
proceeds from preferred shares - series a | ||||||||||||||||||||
minimum lease payments under capital lease | -188,000 | -190,000 | -187,000 | |||||||||||||||||
supplemental disclosure for cash flow information | ||||||||||||||||||||
cash paid for interest | 5,834,000 | 11,706,000 | 73,000 | 259,000 | 357,000 | |||||||||||||||
non-cash investing activities | ||||||||||||||||||||
acquisition of manitoba harvest | -37,490,000 | 0 | 195,407,000 | |||||||||||||||||
acquisition of natura | 0 | 0 | 38,980,000 | |||||||||||||||||
investment in abg profit participation arrangement, net of receivable | 0 | 0 | 94,805,000 | |||||||||||||||||
purchases of investments and s&s acquisition | ||||||||||||||||||||
inventory write-downs | 103,000 | 54,000 | ||||||||||||||||||
non-cash interest expense | 5,206,000 | -46,000 | ||||||||||||||||||
due to related parties | -72,000 | -780,000 | ||||||||||||||||||
proceeds from sale and maturities of short-term investments | ||||||||||||||||||||
proceeds from issuance of convertible preferred stock | ||||||||||||||||||||
acquisition of investments | ||||||||||||||||||||
non-cash interest income | -322,000 | |||||||||||||||||||
increase in deposits and other assets | ||||||||||||||||||||
proceeds from maturities of short-term investments | 0 | |||||||||||||||||||
repayment under privateer holdings debt facilities | 0 | |||||||||||||||||||
advances under privateer holdings construction facilities | ||||||||||||||||||||
non-cash financing activities | ||||||||||||||||||||
shares issued for employee compensation | 649,000 | |||||||||||||||||||
foreign currency gain | 5,618,000 | -1,591,000 | ||||||||||||||||||
benefit from doubtful accounts and returns | ||||||||||||||||||||
depreciation and amortization | 1,010,000 | 1,404,000 | ||||||||||||||||||
(gain) loss on disposal of property and equipment | ||||||||||||||||||||
loss on sale of investment | ||||||||||||||||||||
amortization of discount on convertible senior notes due 2023 | ||||||||||||||||||||
decrease (increase) in deposits and other assets | ||||||||||||||||||||
proceeds from sale of short-term investments | ||||||||||||||||||||
advances under privateer holdings debt facilities | -247,000 | |||||||||||||||||||
repayment of mortgage debt | ||||||||||||||||||||
proceeds from mortgage debt | ||||||||||||||||||||
payments on long-term debt | ||||||||||||||||||||
long-term debt financing costs | ||||||||||||||||||||
proceeds from issuance of convertible senior notes due 2023, net of issuance costs | ||||||||||||||||||||
payment of costs from issuance of common stock pursuant to ipo | 0 | |||||||||||||||||||
effect of foreign currency translation on cash, cash equivalents and restricted cash | ||||||||||||||||||||
cash, cash equivalents and restricted cash | ||||||||||||||||||||
increase in cash, cash equivalents and restricted cash | ||||||||||||||||||||
cash, cash equivalents and restricted cash, end of period | ||||||||||||||||||||
capital lease obligation | ||||||||||||||||||||
conversion of preferred stock to common stock | ||||||||||||||||||||
non-cash investing | ||||||||||||||||||||
addition to property and equipment under capital lease | ||||||||||||||||||||
alef acquisition | ||||||||||||||||||||
(gain) loss on disposal of property, plant and equipment | ||||||||||||||||||||
purchases of short-term investments | -14,667,000 | |||||||||||||||||||
proceeds from sales of short-term investments | 0 | |||||||||||||||||||
purchases of property, plant and equipment | -9,839,000 | |||||||||||||||||||
dispositions of property, plant and equipment | 23,000 | |||||||||||||||||||
lease payments under capital lease | ||||||||||||||||||||
effect of foreign currency translation on cash | 3,401,000 | |||||||||||||||||||
loss on disposal of property, plant, and equipment | ||||||||||||||||||||
advances under privateer holdings credit facility | ||||||||||||||||||||
advances under privateer holdings construction facility | ||||||||||||||||||||
cash | ||||||||||||||||||||
increase in cash | ||||||||||||||||||||
cash, beginning of period | ||||||||||||||||||||
cash, end of period | ||||||||||||||||||||
1. |
We provide you with 20 years of cash flow statements for Tilray stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as operating cash flows, cash levels, capital expenditures, profits, stock-based compensations and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Tilray stock. Explore the full financial landscape of Tilray stock with our expertly curated income statements.
The information provided in this report about Tilray stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.